Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Jul 21, 2023 1:59pm
132 Views
Post# 35551893

RE:RE:RE:Added to position...

RE:RE:RE:Added to position...

Somewhat agree, but a Kinlytic deal announcement is pretty big thing to gloss over. I think few have looked into it in any detail and do not understand the significance. 

The delays in getting formal signed QAPs deals announced is frustrating but as Cameron previously said this doesn't not mean they are not shipping product, it just means they aren't doing it under a longer term formal supply agreement. Hopefully the QAPs numbers will surprise for third quarter and antigens continue their recovery. All the back office quality system updates and automation should be finally finishing and they have lots of cash available to appease their customers liquidity concerns so if they can't start delivering the goods the list of reasonable and believable excuses is dwindling. We shall see very soon. If recent history is any guide we have been seeing big announcements close to quarterly update time so maybe some surprises in store the next 2-3 weeks  


 

<< Previous
Bullboard Posts
Next >>